Dupilumab Impact on Skin Resident Memory T Cells

NCT03983460 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Dupilumab
DRUG: Optimized TCS treatment
PROCEDURE: Biopsies
PROCEDURE: Skin prick-test
PROCEDURE: Blood sample collection

Sponsor

Association pour la Recherche Clinique et Immunologique